Regarding the SLC22A16 gene, nausea and vomiting severity significantly increased after cycles one and two, mucositis severity significantly increased after cycles one and three, and stomachache severity significantly increased after cycle one in patients carrying the AA genotype compared to before chemotherapy (p < 0.05). The gene discussed is SLC22A16; the disease is mucositis.